Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TDG | CCZ |
|---|---|---|
| Price | $1,108.43 | $64.67 |
| Change today | ▲ 0.29% | ▲ 0.00% |
| Market cap | $61.27B | $61.26B |
| Return, 3 months | -16.2% | +2.7% |
| Return, year to date | -16.6% | +10.1% |
| Return, 1 year | -14.7% | +6.5% |
| P/E (TTM) | 33.6 | – |
| P/B | -6.2 | – |
| P/E percentile vs own 5y | 0th | 0th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +22.5% | – |
| Net profit growth (YoY) | +9.5% | – |
| Gross margin | 59.6% | – |
| Operating margin | 46.5% | – |
| Net margin | 19.1% | – |
| Return on equity | – | – |
| Analyst target vs. price | +34.2% | – |
| Analyst buy share | 42% | – |
| RSI (14) | 41 | 41 |
| 30-day volatility | 20.9% | 18.2% |
| Max drawdown, 1 year | -25.8% | -6.5% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.